NorthWest Biotherapeutics Inc (NWBO)

[Virgilio]

It's a buyout (not a sale of assets), so no need to report anything as the shares did not change hands IMO. However, it is quite obvious that if Cognate would decide to sell all of its shares, the share price of the co. would crater. In my opinion, in order to avoid this, I do believe that in the sale's agreement there were lock-up provisions for a certain amount of time (eventually accelerated in case of release of interim data and / or PIII results).